MinterEllison assisted BARD1 Life Sciences Limited (BD1) on its institutional placement and share purchase plan. BARD1 Life Sciences Limited (ASX:BD1) is expected to raise a total of...
BARD1’s $17 Million Capital Raising
Ena Respiratory’s AU$32 Million Funding
MinterEllison has advised Ena Respiratory Pty Ltd, an investee company of the Medical Research Commercialisation Fund managed by Brandon Capital, on its demerger and transformative funding...